A Phase II, Randomised, Four-Way Crossover Study to Compare the Steady State Pharmacokinetics of Testosterone Following Application of Different Testosterone Metered Dose (MD) Lotion Formulations and Doses in Hypogonadal Men.
Phase of Trial: Phase II
Latest Information Update: 06 Jan 2011
At a glance
- Drugs Testosterone (Primary)
- Indications Hypogonadism
- Focus Pharmacokinetics
- Sponsors Acrux DDS
- 06 Jan 2011 Additional lead trial centre identified as reported by ClinicalTrials.gov.
- 06 Jan 2011 Eli Lilly added as trial sponsor and affiliate as reported by ClinicalTrials.gov.
- 11 Mar 2009 New trial record